| | BIVM-ERCC5, ERCC5 (A98V +1 more) | Single nucleotide variant (missense variant) | Xeroderma pigmentosum, group G +1 more | |
| | BIVM-ERCC5, ERCC5 (R214C +1 more) | Single nucleotide variant (missense variant) | Cerebrooculofacioskeletal syndrome 3 +2 more | |
| | BIVM-ERCC5, ERCC5 (R214H +1 more) | Single nucleotide variant (missense variant) | Xeroderma pigmentosum, group G +2 more | |
| | | Single nucleotide variant (splice acceptor variant) | not provided +2 more | GPathogenic/Likely pathogenic |
| | BIVM-ERCC5, ERCC5 (A347S +1 more) | Single nucleotide variant (missense variant) | Cerebrooculofacioskeletal syndrome 3 +2 more | |
| | BIVM-ERCC5, ERCC5 (P524L +1 more) | Single nucleotide variant (missense variant) | not specified +3 more | |
| | ERCC5, LOC126861834 +1 more (A761T +1 more) | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +3 more | |
| | BIVM-ERCC5, ERCC5 +1 more (R819W +1 more) | Single nucleotide variant (missense variant) | Xeroderma pigmentosum, group G +1 more | |
| | BIVM-ERCC5, ERCC5 (V940M +1 more) | Single nucleotide variant (missense variant) | Inborn genetic diseases +5 more | GConflicting classifications of pathogenicity |
| | ERCC5, BIVM-ERCC5 (R1080Q +2 more) | Single nucleotide variant (missense variant) | Xeroderma pigmentosum, group G +3 more | |
| | BIVM-ERCC5, ERCC5 (K1185T +1 more) | Single nucleotide variant (missense variant) | Xeroderma pigmentosum, group G +3 more | |